Expression of Wnt5a in tooth germs and the related signal transduction analysis

Archives of Oral Biology

Volumn 55, Issue 2, 2010, Pages 108-114

  Peng, L ^a,b   Dong, G ^a   Xu, P ^a   Ren, L B ^a   Wang, C L ^a   Aragon, Melissa ^c   Zhou, X D ^a,b   Ye, L ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Human dental papilla cells (HDPCs); Signal transductions; Wnt5a

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ADENOVIRUS; ANALYSIS OF VARIANCE; ARTICLE; CADAVER; FETUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT; TOOTH FLORA; WESTERN BLOTTING;

ADENOVIRIDAE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CADAVER; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ODONTOGENESIS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOOTH GERM; TRANSCRIPTION FACTORS; WNT PROTEINS;

ADENOVIRIDAE;

EID: 74449090483     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2009.12.002     Document Type: Article

References (24)

1. Mikels A.J., and Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 25 57 (2006) 7461-7468
2. Cadigan K.M., and Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 11 24 (1997) 3286-3305
3. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14 (1998) 59-88
4. Miller J.R. The Wnts. Genome Biol 3 1 (2002) REVIEWS3001 [Epub 2001 December 28]
5. Kikuchi A., Yamamoto H., and Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal 19 4 (2007) 659-671
6. Topol L., Jiang X., Choi H., Garrett-Beal L., Carolan P.J., and Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162 5 (2003) 753-755
7. Sarkar L., and Sharpe P.T. Expression of Wnt signalling pathway genes during tooth development. Mech Dev 85 1-2 (1999) 197-200
8. Iozzo R.V., Eichstetter I., and Danielson K.G. Aberrant expression of the growth factor Wnt-5A in human malignancy. Cancer Res 55 16 (1995) 3495-3499
9. Lejeune S., Huguet E.L., Hamby A., Poulsom R., and Harris A.L. Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res 1 2 (1995) 215-222
10. Miletich I., and Sharpe P.T. Normal and abnormal dental development. Hum Mol Genet 12 (2003) R69-R73
11. Yu J.M., Jun E.S., Jung J.S., Suh S.Y., Han J.Y., Kim J.Y., et al. Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257 2 (2007) 172-181
12. Liang H., Chen Q., Coles A.H., Anderson S.J., Pihan G., Bradley A., et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4 5 (2003) 349-360
13. Liu Y., Bhat R.A., Seestaller-Wehr L.M., Fukayama S., Mangine A., Moran R.A., et al. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol 21 2 (2007) 376-387
14. 2+ signaling. Nat Rev Mol Cell Biol 1 1 (2000) 11-21
15. Bootman M.D., Lipp P., and Berridge M.J. Calcium microdomains: organization and function. Cell Calcium 114 (2001) 2213-2222
16. 2+-dependent routes to Ras: mechanisms for neuronal survival, differentiation, and plasticity?. Neuron 16 2 (1996) 233-236
17. Melien O., Nilssen L.S., Dajani O.F., Sand K.L., Iversen J.G., Sandnes D.L., et al. Ca2+-mediated activation of ERK in hepatocytes by norepinephrine and prostaglandin F2 alpha: role of calmodulin and Src kinases. BMC Cell Biol 3 (2002) 5. http://www.biomedcentral.com/1471-2121/3/5
18. Impey S., Obrietan K., Wong S.T., Poser S., Yano S., Wayman G., et al. Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 21 4 (1998) 869-883
19. Molnár A., Theodoras A.M., Zon L.I., and Kyriakis J.M. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/ERK. J Biol Chem 272 20 (1997) 13229-13235
20. Ellinger-Ziegelbauer H., Kelly K., and Siebenlist U. Cell cycle arrest an d reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase kinase kinase 3. Mol Cell Biol 19 5 (1999) 3857-3868
21. Oishi I., Suzuki H., Onishi N., Takada R., Kani S., Ohkawara B., et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cell 8 7 (2003) 645-654
22. Sowa H., Kaji H., Yamaguchi T., Sugimoto T., and Chihara K. Activations of P42/441/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277 39 (2002) 36024-36031
23. Tuli R., Tuli S., Nandi S., Huang X., Manner P.A., Hozack W.J., et al. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278 42 (2003) 41227-41236
24. Osaki M., Oshimura M., and Iho H. P13K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9 6 (2004) 667-676